Results 11 to 20 of about 36,003 (284)

Topiramate‐induced nephrolithiasis [PDF]

open access: yesClinical Case Reports, 2015
Key Clinical MessageNephrolithiasis is a less common side effect of the antiepileptic drug topiramate. We report the case of a 3‐year‐old boy who presented to the emergency department with abdominal pain; examinations revealed a large calcification in the left kidney. Regular ultrasound examinations are recommended in children using topiramate.
Giannopoulou, Eleni Z   +5 more
openaire   +2 more sources

Topiramate Induced Restless Legs Syndrome: Case Report

open access: yesTürk Uyku Tıbbı Dergisi, 2014
Several medications can exacerbate or cause Restless Legs syndrome (RLS). Topiramate is an antiepileptic drug used to epilepsy and migraine treatment. In literature, number of case with topiramate induced RLS is very rare.
Selda Korkmaz, Murat Aksu
doaj   +1 more source

Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity.

open access: yesPLoS ONE, 2021
Topiramate is an anti-epileptic drug that is commonly prescribed not just to prevent seizures but also migraine headaches, with over 8 million prescriptions dispensed annually.
Syed K Rafi   +8 more
doaj   +1 more source

Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy [PDF]

open access: yes, 2013
<p>Background: Anticonvulsants have been used to manage psychiatric conditions for over 50 years. It is recognised that some, particularly valproate, carbamazepine and lamotrigine, are human teratogens, while others including topiramate require ...
A Basan   +23 more
core   +2 more sources

Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. [PDF]

open access: yes, 2016
BACKGROUND: Prior studies have shown that switching patients from inducing antiepileptic drugs (AEDs) to lamotrigine, levetiracetam, or topiramate reduces serum lipids and C-reactive protein (CRP). These studies were all of short duration, and some drugs,
Chervoneva, Inna   +6 more
core   +2 more sources

Topiramate modulates trigeminal pain processing in thalamo-cortical networks in humans after single dose administration. [PDF]

open access: yesPLoS ONE, 2017
Migraine is the sixth most common cause of disability in the world. Preventive migraine treatment is used to reduce frequency, severity and duration of attacks and therefore lightens the burden on the patients' quality of life and reduces disability ...
Julia M Hebestreit, Arne May
doaj   +1 more source

Lennox-Gastaut Syndrome: A State of the Art Review. [PDF]

open access: yes, 2017
Lennox-Gastaut syndrome (LGS) is a severe age-dependent epileptic encephalopathy usually with onset between 1 and 8 years of age. Functional neuroimaging studies recently introduced the concept of Lennox-Gastaut as "secondary network epilepsy" resulting ...
Mastrangelo, Mario
core   +1 more source

Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation [PDF]

open access: yes, 2018
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives.
Ahmed, Fayyaz   +8 more
core   +3 more sources

Nephrolithiasis and Nephrocalcinosis From Topiramate Therapy in Children With Epilepsy

open access: yesKidney International Reports, 2018
Introduction: Adults treated with topiramate may develop nephrolithiasis, but its frequency in children on topiramate is unknown. Topiramate inhibits renal carbonic anhydrase, which can lead to renal tubular acidosis and hypercalciuria.
Sarah M. Barnett   +4 more
doaj   +1 more source

Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study. [PDF]

open access: yes, 2017
Brivaracetam (BRV), a selective, high-affinity ligand for synaptic vesicle protein 2A, is a new antiepileptic drug (AED) for adjunctive treatment of focal (partial-onset) seizures in adults with epilepsy.
Asadi-Pooya, Ali A.   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy